Literature DB >> 30312725

Long non-coding RNA NEAT1 promotes colorectal cancer progression by competitively binding miR-34a with SIRT1 and enhancing the Wnt/β-catenin signaling pathway.

Yang Luo1, Jian-Jun Chen1, Qiang Lv2, Jun Qin1, Yi-Zhou Huang1, Min-Hao Yu3, Ming Zhong4.   

Abstract

In recent years, accumulating evidence has indicated that long non-coding RNAs (lncRNAs) are powerful factors influencing the progression of multiple malignancies. Although a relationship between the lncRNA NEAT1 (nuclear enriched abundant transcript 1) and colorectal cancer has previously been reported, the functional mechanism underlying the involvement of NEAT1 in colorectal cancer remains unknown. In this study, we report that NEAT1 expression is up-regulated in colorectal cancer tissues, which correlates with advanced clinical features, poor overall survival and disease free survival. Up-regulated NEAT1 promotes cell proliferation and metastasis of colorectal cancer both in vitro and in vivo. Moreover, NEAT1 functions as an oncogene influencing cell viability and invasion in part by serving as a competing endogenous RNA (ceRNAs) modulating miRNA-34a expression, leading to subsequent repression of the miR-34a/SIRT1 axis and activation of the Wnt/β-catenin signaling pathway. Taken together, our study demonstrates that the lncRNA NEAT1 may serve as a prognostic biomarker and a potential therapeutic target in colorectal cancer.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; NEAT1; SIRT1; Wnt/β-catenin signaling pathway; miR-34a

Mesh:

Substances:

Year:  2018        PMID: 30312725     DOI: 10.1016/j.canlet.2018.10.002

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  57 in total

1.  Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma.

Authors:  Yu-Zhen Yin; Shi-Hua Yao; Chun-Guang Li; Yu-Shui Ma; Zhou-Jun Kang; Jia-Jia Zhang; Cheng-You Jia; Li-Kun Hou; Shan-Shan Qin; Xin Fan; Han Zhang; Meng-Die Yang; Dan-Dan Zhang; Gai-Xia Lu; Hui-Min Wang; Li-Peng Gu; Lin-Lin Tian; Pei-Yao Wang; Ping-Sheng Cao; Wei Wu; Zi-Yang Cao; Zhong-Wei Lv; Bo-Wen Shi; Chun-Yan Wu; Geng-Xi Jiang; Da Fu; Fei Yu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

Review 2.  Updates on the epigenetic roles of sirtuins.

Authors:  Tatsiana Kosciuk; Miao Wang; Jun Young Hong; Hening Lin
Journal:  Curr Opin Chem Biol       Date:  2019-03-12       Impact factor: 8.822

Review 3.  The emerging role of long noncoding RNAs in esophageal carcinoma: from underlying mechanisms to clinical implications.

Authors:  Siyuan Luan; Yushang Yang; Yuxin Zhou; Xiaoxi Zeng; Xin Xiao; Bo Liu; Yong Yuan
Journal:  Cell Mol Life Sci       Date:  2021-01-19       Impact factor: 9.261

Review 4.  Association of sirtuins (SIRT1-7) with lung and intestinal diseases.

Authors:  Yuhan Chen; Di Zhou; Yuan Feng; Bingxin Li; Yong Cui; Gang Chen; Ning Li
Journal:  Mol Cell Biochem       Date:  2022-05-20       Impact factor: 3.396

5.  Comprehensive analysis of immune related lncRNAs in the tumor microenvironment of stage II-III colorectal cancer.

Authors:  Zan Zhang; Yixin Wu; Changyuan Yu; Zhengtai Li; Lida Xu
Journal:  J Gastrointest Oncol       Date:  2021-10

Review 6.  Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.

Authors:  Rebecca Morgan; Willian Abraham da Silveira; Ryan Christopher Kelly; Ian Overton; Emma H Allott; Gary Hardiman
Journal:  Expert Rev Mol Diagn       Date:  2021-11-25       Impact factor: 5.225

Review 7.  Basic approaches, challenges and opportunities for the discovery of small molecule anti-tumor drugs.

Authors:  Yu-Shui Ma; Ji-Bin Liu; Xiao-Li Yang; Rui Xin; Yi Shi; Dan-Dan Zhang; Hui-Min Wang; Pei-Yao Wang; Qin-Lu Lin; Wen Li; Da Fu
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 8.  The comprehensive landscape of miR-34a in cancer research.

Authors:  Sijing Li; Xiaohui Wei; Jinyong He; Quanquan Cao; Danyu Du; Xiaoman Zhan; Yuqi Zeng; Shengtao Yuan; Li Sun
Journal:  Cancer Metastasis Rev       Date:  2021-05-06       Impact factor: 9.264

Review 9.  Circular RNAs in Lung Cancer: Recent Advances and Future Perspectives.

Authors:  Huan-Huan Chen; Tie-Ning Zhang; Qi-Jun Wu; Xin-Mei Huang; Yu-Hong Zhao
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

10.  Exosomal lncRNA NEAT1 from cancer-associated fibroblasts facilitates endometrial cancer progression via miR-26a/b-5p-mediated STAT3/YKL-40 signaling pathway.

Authors:  Jiang-Tao Fan; Zhao-Yu Zhou; Yan-Lu Luo; Qin Luo; Si-Bang Chen; Jin-Che Zhao; Qiao-Ru Chen
Journal:  Neoplasia       Date:  2021-06-18       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.